Cosmesis Outcomes for Sector Resection for Ductal Carcinoma In Situ (DCIS)

Fosh, Beverley; Hainsworth, Alison; Beumer, Jesse D.; Howes, Benjamin H.L.; McLeay, William; Eaton, Michael

doi:10.1245/s10434-013-3441-4

Cited by 15 publications

(8 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The majority ( n = 29, 72.5 per cent) did not define ‘delay’, and reported number of days/weeks until radiotherapy, chemotherapy or first adjuvant treatment. A minority of studies ( n = 10, 25.0 per cent) defined delays to adjuvant therapy with varying temporal cut-offs, for example less than or equal to 4 weeks ( n = 2) 15 , 48 , 6 weeks ( n = 4) 8 , 32 , 41 , 67 and 8 weeks ( n = 2) 35 , 68 after operation. Two studies differentiated the cut-off for chemotherapy and radiotherapy as 6 and 8 weeks after surgery, respectively 52 , 69 .…”

Section: Resultsmentioning

confidence: 99%

“…Aesthetic outcome was assessed by the patient and clinician ( n = 25, 33.3 per cent) 31 , 36 , 38 , 40 , 42 , 45 , 58 , 65 , 66 , 70 , 76 , 88 , 91–93 , 102 , 103 , 108 , 111 , 112 , 116 , 118–121 , clinician only ( n = 25, 33.3 per cent) 39 , 63 , 68 , 73 , 78 , 79 , 81 , 85 , 96 , 97 , 99–101 , 107 , 113 , 122–126 , patient only ( n = 22, 29.3 per cent) 2 , 47 , 49 , 54 , 64 , 67 , 72 , 74 , 89 , 94 , 109 , 110 , 114 , 117 , 127–135 or was unclear ( n = 2, 2.7 per cent) 95 , 136 . Very few studies ( n = 4) included non-medical staff in aesthetic rating panels …”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Outcome reporting in therapeutic mammaplasty: a systematic review

et al. 2021

View full text Add to dashboard Cite

Background Therapeutic mammaplasty (TM) is an oncological procedure which combines tumour resection with breast reduction and mastopexy techniques. Previous systematic reviews have demonstrated the oncological safety of TM but reporting of critically important outcomes, such as quality of life, aesthetic and functional outcomes, are limited, piecemeal or inconsistent. This systematic review aimed to identify all outcomes reported in clinical studies of TM to facilitate development of a core outcome set. Methods Medline, EMBASE, CINAHL and Web of Science were searched from inception to 5 August 2020. Included studies reported clinical outcomes following TM for adult women. Two authors screened articles independently for eligibility. Data were extracted regarding the outcome definition and classification type (for example, oncological, quality of life, etc.), time of outcome reporting and measurement tools. Results Of 5709 de-duplicated records, 148 were included in the narrative synthesis. The majority of studies (n = 102, 68.9 per cent) reported measures of survival and/or recurrence; approximately three-quarters (n = 75, 73.5 per cent) had less than 5 years follow-up. Aesthetic outcome was reported in half of studies (n = 75, 50.7 per cent) using mainly subjective, non-validated measurement tools. The time point at which aesthetic assessment was conducted was highly variable, and only defined in 48 (64.0 per cent) studies and none included a preoperative baseline for comparison. Few studies reported quality of life (n = 30, 20.3 per cent), functional outcomes (n = 5, 3.4 per cent) or resource use (n = 28, 18.9 per cent). Conclusion Given the oncological equivalence of TM and mastectomy, treatment decisions are often driven by aesthetic and functional outcomes, which are infrequently and inconsistently reported with non-validated measurement tools.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Outcome reporting in therapeutic mammaplasty: a systematic review

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Several authors have noted improved patient satisfaction and outcomes with oncoplastic techniques. 6,25 General satisfaction scores reported by patients reached 87% with immediate flap reconstruction 14,15 Spiegel et al reported that 11 out of 12 (91%) patients graded their result as good to excellent after free flap partial breast reconstruction, with only one grade of "fair" due to dissatisfaction with intra-flap fat necrosis resulting from revision liposuction. 9 With 60 to 70% of early-stage breast cancers treated with BCT and 20 to 30% of them having fair to poor aesthetic outcomes, the number of patients who could benefit from oncoplastic reconstruction is potentially as large as that undergoing mastectomy with reconstruction.…”

Section: Discussionmentioning

confidence: 99%

Defining the Role of Free Flaps in Partial Breast Reconstruction

Smith

Molina

Dayan

et al. 2017

J reconstr Microsurg

View full text Add to dashboard Cite

Free and pedicled flaps are useful for partial breast reconstruction, particularly in breast cancer patients with small breasts undergoing breast-conserving treatment (BCT). Flap selection depends on defect size, location, and donor tissue availability. Medial defects are difficult to reconstruct using pedicled flaps due to arc of rotation and intervening breast tissue. Free tissue transfer can overcome these obstacles. Confirming negative margins before flap reconstruction ensures harvest of adequate volume and avoids later re-operation. Judicious use of free flaps for oncoplastic reconstruction expands the possibility for breast conservation.

show abstract

“…It was developed with extensive qualitative input from patients and Rasch psychometric measures [16]. Postoperative modules were later developed to evaluate outcomes after mastectomy without reconstruction [42] and breast-conserving therapy [43][44][45].…”

Section: Breast-qmentioning

confidence: 99%

Incorporating Patient-Reported Outcome Measures into Breast Surgical Oncology: Advancing Toward Value-Based Care

et al. 2019

View full text Add to dashboard Cite

Value in health care is defined as the health outcome achieved per unit of cost. For health care systems, improving value means achieving better outcomes at lower costs. Improving outcomes, including patient-reported outcomes (PROs), as well as more established metrics such as mortality and complication rates, ensures high-quality care. This is particularly true in breast cancer surgery, where survival and recurrence rates are comparable across different surgical approaches. Outcomes reflecting survivorship quality may therefore better inform decision making regarding surgical approaches. PROs can be assessed using validated instruments known as patient-reported outcome measures (PROMs). They are obtained directly from patients reflecting their health-related quality of life (HRQOL).Ongoing initiatives strive to define PROMs that accurately reflect HRQOL and demonstrate value, with the goal of establishing benchmarks for quality of care. Clinicians caring for patients with breast cancer are well positioned to be involved in defining meaningful measures of value-based breast cancer care. This article reviews value-based breast cancer care in the context of locoregional therapy, with attention paid to the work done by the International Consortium of Health Outcome Measures in which a "standard set" of value-based patient-centered outcomes for breast cancer for international use is defined. In addition, an overview is provided of relevant PROMs and previously reported scores. Recommendations and future challenges for implementation of routine collection of PROs are also discussed. The Oncologist 2020;25:384-390 Implications for Practice: Opportunity exists to act as early adopters of the routine collection of longitudinal patientreported outcome data for breast cancer, allowing transition of current care to value-based cancer care.

show abstract

Cosmesis Outcomes for Sector Resection for Ductal Carcinoma In Situ (DCIS)

Abstract: Oncoplastic techniques used for partial mastectomies to provide greater oncological clearance resulted in a high level of patient satisfaction after surgery.

Cited by 15 publications

References 11 publications

Outcome reporting in therapeutic mammaplasty: a systematic review

Outcome reporting in therapeutic mammaplasty: a systematic review

Defining the Role of Free Flaps in Partial Breast Reconstruction

Incorporating Patient-Reported Outcome Measures into Breast Surgical Oncology: Advancing Toward Value-Based Care

Contact Info

Product

Resources

About